OLATHE — The Kansas Bioscience Authority will consider up to $29.7 million in new investments in the upcoming fiscal year, according to a plan approved by its executive committee on Wednesday.
The plan includes about $20 million for commercialization projects and $9.7 million for research and development.
David Vranicar, the authority’s interim president and CEO, said that the total available amount for investments fell slightly from last year’s total, when about $36 million was spent on investments.
That’s partially because of caps on state funding for the authority and partially because of the authority’s judgments on the appropriate amount of funding
To read the full, original article click on this link: Kansas Bioscience Authority considering almost $30 million in new investments / LJWorld.com
Author: Andy Hyland
